![Taka Koda](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Taka Koda
Private Equity Investor bij Remiges Ventures Inc.
Actieve functies van Taka Koda
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Remiges Ventures Inc.
![]() Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Private Equity Investor | 01-07-2019 | - |
Digestome Therapeutics, Inc.
![]() Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Corporate Officer/Principal | 01-06-2017 | - |
Loopbaan van Taka Koda
Eerdere bekende functies van Taka Koda
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Mitsui & Co. Global Investment, Inc.
![]() Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01-04-2012 | 01-03-2014 |
Mitsui & Co. Global Investment Ltd.
![]() Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Private Equity Investor | 01-04-2009 | 01-03-2012 |
QD LASER, INC. | Corporate Officer/Principal | 01-01-2008 | 01-03-2009 |
MITSUI & CO., LTD. | Corporate Officer/Principal | 01-04-2003 | 01-03-2007 |
Opleiding van Taka Koda
University of Tokyo | Undergraduate Degree |
Hoshi University | Undergraduate Degree |
Statistieken
Internationaal
Japan | 6 |
Verenigde Staten | 4 |
Operationeel
Corporate Officer/Principal | 3 |
Private Equity Investor | 3 |
Undergraduate Degree | 2 |
Sectoraal
Finance | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MITSUI & CO., LTD. | Process Industries |
QD LASER, INC. | Electronic Technology |
Bedrijven in privébezit | 4 |
---|---|
Mitsui & Co. Global Investment, Inc.
![]() Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Finance |
Mitsui & Co. Global Investment Ltd.
![]() Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Finance |
Remiges Ventures Inc.
![]() Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Finance |
Digestome Therapeutics, Inc.
![]() Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Health Services |